Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1998

Hydrolytic activity of candida albicans and their susceptibility to antimycotics

Elżbieta Krajewska-Kułak, Wiaczesław Niczyporuk

Med Sci Monit 1998; 4(4): BR616-620 :: ID: 502120

Abstract

We used 320 strains of Candida albicans, isolated from healthy women (n=95) and from those with vulvovaginitis candidiasis(n=225). The aim of this study was to assess the hydrolytic activity of the tested strains and their resistance to antimycotics from healthy women and from women with vulvovaginitis. Generally 30.03% strains of Candida albicans were resistant to all tested antimycotics. 39.46% of isolates from women with vulvovaginitis candidamycetica were resistant to the tested antimycotics in comparison to 7.72% of healthy women. Isolates from women with vulvovaginitis candidamycetica were resistant to fluconazole (72%), pimaricine (65.33%) and ketoconazole (58.67%). Among isolates from healthy women, no resistant strains to 5-fluorocytosine were found. 82.22% of isolates from women with vulvovaginitis were resistant to two or more drugs, incomparison to and only 14.74% of isolates from healthy women. Isolates from women with vulvovaginitis incomparison with healthy, women had a significanty higher hydrolytic activity. Isolates from women with vaginitis, had the highest activity of leucine arylamidase, lipase esterase and esterase. Isolates from healthy women had the highest activity of leucine arylamidase, esterase and esterase lipase. We found, no activity of b-glucuronidase. Isolates from women with vaginitis had a high resistance to the tested antimycotics and a higher hydrolytic activity.

Keywords: Candida albicans, API ZYM, antimycogram

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

12 Mar 2024 : Review article  

Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies

Med Sci Monit In Press; DOI: 10.12659/MSM.943240  

0:00

12 Mar 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Med Sci Monit In Press; DOI: 10.12659/MSM.943360  

0:00

14 Mar 2024 : Clinical Research  

Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...

Med Sci Monit In Press; DOI: 10.12659/MSM.943956  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750